Efficacy Studies
PROTECT: promotion: Dietmar-Hopp Foundation; ClinicalTrials.gov: NCT02907658
In a two-armed randomised-controlled efficacy trial over 12 months the PROTECT programme was investigated for its longitudinal efficacy under study conditions. ClinicalTrials.gov: NCT02907658. Results were reached through multilevel analyses. A significant reduction in core symptoms of Gaming and Internet Disorder was observed after 12 months (d = 0.63; p < 0.001) with a significant interaction effect (time*group; p = 0.028). The efficacy trial was funded by the Dietmar-Hopp Foundation with a funding volume of 115,000 €.
PROTECT+: gov: NCT03582839
In a one-armed clinical study, therapy effects of PROTECT+ were investigated in N = 54 adolescent patients in an outpatient group therapy setting over 12 months. ClinicalTrials.gov: NCT03582839. The core symptomatology was reduced 12 months past intervention with medium to large effects. This was observed in both, self-report and parent-report data. The efficacy trial was supported by an internal research promotion by the University of Education Heidelberg with a funding volume of 39,234 €.